8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001558370-23-002104
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading plx-20230227x8k.htm…